πŸ‡ΊπŸ‡Έ FDA
Patent

US 10532986

Cyclic compound acting as PDE4 inhibitor

granted A61KA61K31/4184A61K31/423

Quick answer

US patent 10532986 (Cyclic compound acting as PDE4 inhibitor) held by Medshine Discovery Inc. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4184, A61K31/423, A61P, A61P29/00